Reduction of tissue norepinephrine and aortic pressure in spontaneously hypertensive rats by 1,2,3,5-tetrahydroimidazo(2,1-b)quinazoline.
D000818:Animals; D001921:Brain / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D011799:Quinazolines / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors
D007093:Imidazoles; D011799:Quinazolines; D012701:Serotonin; D009638:Norepinephrine